IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis.
Catapano M, Vergnano M, Romano M, Mahil SK, Choon SE, Burden AD, Young HS, Carr IM, Lachmann HJ, Lombardi G, Smith CH, Ciccarelli FD, Barker JN, Capon F.
Catapano M, et al.
J Invest Dermatol. 2020 Apr;140(4):816-826.e3. doi: 10.1016/j.jid.2019.08.444. Epub 2019 Sep 17.
J Invest Dermatol. 2020.
PMID: 31539532
Free PMC article.